Priming of naive T cells inside tumors leads to eradication of established tumors

Ping Yu, Youjin Lee, Wenhua Liu, Robert K. Chin, Jing Wang, Yang Wang, Andrea Schietinger, Mary Philip, Hans Schreiber, Yang Xin Fu

Research output: Contribution to journalArticle

261 Citations (Scopus)

Abstract

The tumor barrier comprised of nonantigenic stromal cells may contribute to the failure of tumor rejection. The tumor-necrosis factor superfamily member LIGHT (also known as TNFSF-14) is a ligand of stromal cell-expressed lymphotoxin-β receptor and T cell-expressed herpes viral entry mediator (HVEM). Here we show that forced expression of LIGHT in the tumor environment induces a massive infiltration of naive T lymphocytes that correlates with an upregulation of both chemokine production and expression of adhesion molecules. Activation of these infiltrating T cells, possibly through HVEM, leads to the rejection of established, highly progressive tumors at local and distal sites. Our study indicates that targeting the tumor barrier may be an effective strategy for cancer immunotherapy.

Original languageEnglish (US)
Pages (from-to)141-149
Number of pages9
JournalNature Immunology
Volume5
Issue number2
DOIs
StatePublished - Feb 1 2004

Fingerprint

T-Lymphocytes
Neoplasms
Stromal Cells
Light
Lymphotoxin-alpha
T-Cell Antigen Receptor
Chemokines
Immunotherapy
Up-Regulation
Tumor Necrosis Factor-alpha
Ligands

ASJC Scopus subject areas

  • Immunology

Cite this

Priming of naive T cells inside tumors leads to eradication of established tumors. / Yu, Ping; Lee, Youjin; Liu, Wenhua; Chin, Robert K.; Wang, Jing; Wang, Yang; Schietinger, Andrea; Philip, Mary; Schreiber, Hans; Fu, Yang Xin.

In: Nature Immunology, Vol. 5, No. 2, 01.02.2004, p. 141-149.

Research output: Contribution to journalArticle

Yu, P, Lee, Y, Liu, W, Chin, RK, Wang, J, Wang, Y, Schietinger, A, Philip, M, Schreiber, H & Fu, YX 2004, 'Priming of naive T cells inside tumors leads to eradication of established tumors', Nature Immunology, vol. 5, no. 2, pp. 141-149. https://doi.org/10.1038/ni1029
Yu, Ping ; Lee, Youjin ; Liu, Wenhua ; Chin, Robert K. ; Wang, Jing ; Wang, Yang ; Schietinger, Andrea ; Philip, Mary ; Schreiber, Hans ; Fu, Yang Xin. / Priming of naive T cells inside tumors leads to eradication of established tumors. In: Nature Immunology. 2004 ; Vol. 5, No. 2. pp. 141-149.
@article{21d551aeaec7486cb0d4d6ead13a62ae,
title = "Priming of naive T cells inside tumors leads to eradication of established tumors",
abstract = "The tumor barrier comprised of nonantigenic stromal cells may contribute to the failure of tumor rejection. The tumor-necrosis factor superfamily member LIGHT (also known as TNFSF-14) is a ligand of stromal cell-expressed lymphotoxin-β receptor and T cell-expressed herpes viral entry mediator (HVEM). Here we show that forced expression of LIGHT in the tumor environment induces a massive infiltration of naive T lymphocytes that correlates with an upregulation of both chemokine production and expression of adhesion molecules. Activation of these infiltrating T cells, possibly through HVEM, leads to the rejection of established, highly progressive tumors at local and distal sites. Our study indicates that targeting the tumor barrier may be an effective strategy for cancer immunotherapy.",
author = "Ping Yu and Youjin Lee and Wenhua Liu and Chin, {Robert K.} and Jing Wang and Yang Wang and Andrea Schietinger and Mary Philip and Hans Schreiber and Fu, {Yang Xin}",
year = "2004",
month = "2",
day = "1",
doi = "10.1038/ni1029",
language = "English (US)",
volume = "5",
pages = "141--149",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Priming of naive T cells inside tumors leads to eradication of established tumors

AU - Yu, Ping

AU - Lee, Youjin

AU - Liu, Wenhua

AU - Chin, Robert K.

AU - Wang, Jing

AU - Wang, Yang

AU - Schietinger, Andrea

AU - Philip, Mary

AU - Schreiber, Hans

AU - Fu, Yang Xin

PY - 2004/2/1

Y1 - 2004/2/1

N2 - The tumor barrier comprised of nonantigenic stromal cells may contribute to the failure of tumor rejection. The tumor-necrosis factor superfamily member LIGHT (also known as TNFSF-14) is a ligand of stromal cell-expressed lymphotoxin-β receptor and T cell-expressed herpes viral entry mediator (HVEM). Here we show that forced expression of LIGHT in the tumor environment induces a massive infiltration of naive T lymphocytes that correlates with an upregulation of both chemokine production and expression of adhesion molecules. Activation of these infiltrating T cells, possibly through HVEM, leads to the rejection of established, highly progressive tumors at local and distal sites. Our study indicates that targeting the tumor barrier may be an effective strategy for cancer immunotherapy.

AB - The tumor barrier comprised of nonantigenic stromal cells may contribute to the failure of tumor rejection. The tumor-necrosis factor superfamily member LIGHT (also known as TNFSF-14) is a ligand of stromal cell-expressed lymphotoxin-β receptor and T cell-expressed herpes viral entry mediator (HVEM). Here we show that forced expression of LIGHT in the tumor environment induces a massive infiltration of naive T lymphocytes that correlates with an upregulation of both chemokine production and expression of adhesion molecules. Activation of these infiltrating T cells, possibly through HVEM, leads to the rejection of established, highly progressive tumors at local and distal sites. Our study indicates that targeting the tumor barrier may be an effective strategy for cancer immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=10744227434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744227434&partnerID=8YFLogxK

U2 - 10.1038/ni1029

DO - 10.1038/ni1029

M3 - Article

C2 - 14704792

AN - SCOPUS:10744227434

VL - 5

SP - 141

EP - 149

JO - Nature Immunology

JF - Nature Immunology

SN - 1529-2908

IS - 2

ER -